Cefazolin potency against methicillin-resistant Staphylococcus aureus: a microbiologic assessment in support of a novel drug delivery system for skin and skin structure infections [Erratum]
Authors Nicolau DP, Silberg BN
Received 2 August 2017
Accepted for publication 2 August 2017
Published 16 August 2017 Volume 2017:10 Pages 247—248
Nicolau DP, Silberg BN. Infect Drug Resist. 2017;10:227–230.
Page 227, affiliations list, the text “Department of Surgery, Sonoma West Medical Center, Sebastopol, CT, USA” should read “Department of Surgery, Sonoma West Medical Center, Sebastopol, CA, USA”.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]